Status:
COMPLETED
NI-0801 in Allergic Contact Dermatitis
Lead Sponsor:
Light Chain Bioscience - Novimmune SA
Conditions:
Allergic Contact Dermatitis
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.
Eligibility Criteria
Inclusion
- Aged ≥ 18 and ≤ 70 years
- Either male or a female lacking childbearing potential
- Previously documented nickel allergy
Exclusion
- Any medical condition that, in the opinion of the investigator, would interfere with safe completion of the trial or that would prevent subjects from providing informed consent.
- Known or previous diagnosis of malignancy
- Known current active tuberculosis or a history of active TB within 12 months of screening
- Known infection with HIV, Hepatitis B or C
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01244607
Last Update
November 19 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.